Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,320 papers from all fields of science
Search
Sign In
Create Free Account
Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010
Known as:
MNK-010
, Pegylated Liposomal Docetaxel Prodrug MNK-010
A formulation containing pegylated liposomal nanoparticles encapsulating a prodrug of the poorly water-soluble, second-generation taxane analog…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Microtubule Process
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 3524: Novel prodrugs of the glutamine antagonist 6-diazo-5-oxo-norleucine (DON) as treatment for malignant peripheral nerve sheath tumor
K. Lemberg
,
Ying Wu
,
+7 authors
B. Slusher
Molecular and Cellular Biology / Genetics
2018
Corpus ID: 58619519
Neurofibromatosis Type I (NF1) is a heritable tumor predisposition syndrome in which up to 10% of patients develop malignant…
Expand
2015
2015
Abstract 4400: Anti-tumor activity of liposomal docetaxel prodrug MNK-010 on PC3 human prostate xenografts in mice
R. Fitch
,
J. Wojdyla
,
J. Blackledge
,
W. D. Mcghee
2015
Corpus ID: 79019842
The anti-mitotic taxanes are one of the most important families of anticancer drugs that have broad anti-tumor activity and are…
Expand
2015
2015
Abstract CT230: A phase I first in human dose escalation trial of MNK-010 in subjects with advanced solid tumors
L. Rochon
,
K. Devarakonda
,
+4 authors
A. Sukari
2015
Corpus ID: 79426685
Background: Taxanes possess broad activity and are widely used for a variety of tumor types. Currently available formulations are…
Expand
2015
2015
Abstract 5516: Biodistribution of liposomal docetaxel prodrug MNK-010 in mice bearing A549 human NSCLC xenografts
R. Fitch
,
J. Wible
,
J. Blackledge
,
W. D. Mcghee
2015
Corpus ID: 78991742
The anti-mitotic taxanes belong to one of the most important families of anticancer drugs that have broad anti-tumor activity and…
Expand
2015
2015
2312 Japanese phase I trial of hypoxia-activated prodrug evofosfamide (TH-302) as monotherapy in patients with solid tumors or in combination with gemcitabine in patients with advanced pancreatic…
S. Mitsunaga
,
Hideaki Takahashi
,
+4 authors
M. Ikeda
2015
Corpus ID: 77605654
2015
2015
Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle.
A. Dalhoff
,
M. Rashid
,
T. Kapsner
,
G. Panagiotidis
,
A. Weintraub
,
C. Nord
Clinical Microbiology and Infection
2015
Corpus ID: 35684569
2010
2010
INCREASED EFFECTIVENESS OF GS-424020 A MUTUAL PRODRUG (MPD) CONTAINING SALMETEROL (SAL) AND DESISOBUTRYLCICLESONIDE (DESCIC) OVER ITS COMPONENTS IN THE SHEEP MODEL OF ASTHMA
W. Abraham
,
W. Baker
,
C. Wright
Asian Test Symposium
2010
Corpus ID: 74795361
Review
2009
Review
2009
Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.
L. Tietze
,
Birgit Krewer
Anti-Cancer Agents in Medicinal Chemistry
2009
Corpus ID: 39688903
In recent years, a series of new and highly cytotoxic analogues of CC-1065 and the duocarmycins have been developed that can be…
Expand
2008
2008
Cannabidiol prodrugs, compositions containing cannabidiol prodrugs and methods of use thereof
ジェルジー ゴリンスキー,ミロスロー
,
リン スティンチコーム,オードラ
,
リン ハワード,ジェフェリー
,
リー バンクス スタン
,
ダナ カーメルハンメル
2008
Corpus ID: 224702124
Described herein are cannabidiol prodrugs, methods for producing cannabidiol prodrugs, formulations containing cannabidiol…
Expand
2007
2007
Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
S. Hecker
,
K. Raja Reddy
,
+11 authors
M. Erion
Journal of Medicinal Chemistry
2007
Corpus ID: 7820836
2'-C-Methyladenosine exhibits impressive inhibitory activity in the cell-based hepatitis C virus (HCV) subgenomic replicon assay…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required